SCHEMBL17026727

SCHEMBL17026727

CCOc1cc(CC(=O)O)ccc1OCC1CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MAPT P10636 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
PTGDR2 Q9Y5Y4 6/20 0.52
HTT P42858 2/20 0.51
KDM4E B2RXH2 1/20 0.51
LMNA P02545 1/20 0.48
ALPL P05186 1/20 0.48
ALPI P09923 1/20 0.48
ALPG P10696 1/20 0.48
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
GAA P10253 2/20 0.44
POLB P06746 2/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17026725 0.94 ALDH1A1 (0.54) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL13412905 0.88 CA5A (0.57) ALDH1A1CYP1A2CYP2C19GAATSHR
SCHEMBL1883666 0.87 ALDH1A1 (0.58) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL2525777 0.85 ALDH1A1 (0.57) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
Bromide SCHEMBL10998875 0.85 ALDH1A1 (0.57) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL3054967 0.83 CA5A (0.54) ALDH1A1GAATSHRNFKB1TDP1
SCHEMBL31661761 0.83 CA5A (0.54) ALDH1A1GAATSHRNFKB1TDP1
SCHEMBL8051796 0.82 THRA (0.47) ALDH1A1MAPTPTGDR2KDM4ELMNA
SCHEMBL17316379 0.82 PTGDR2 (0.42) ALDH1A1PTGDR2RXRARXRBRXRG
SCHEMBL13412908 0.82 THRA (0.54) ALDH1A1PTGDR2GAATSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110427-A1 COMPOSITIONS OF PENTOSAN POLYSULFATE SALTS FOR ORAL ADMINISTRATION AND METHODS OF USE Urigen Pharmaceuticals, Inc. (US) 2017-01-04 EP claimed
WO-2015127416-A1 COMPOSITIONS OF PENTOSAN POLYSULFATE SALTS FOR ORAL ADMINISTRATION AND METHODS OF USE URIGEN PHARMACEUTICALS, INC. (US) 2015-08-27 WO claimed